Skip to main content
No.1 Press Release Service in Korea
Search
Search
Login
Create Account
Services
Contact Us
News
Services
About Us
Contact Us
Korean
News
All News
News by Region
Korea
Overseas
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Services
Why Korea Newswire?
How We Distribute
Services & Pricing
Basic
Standard
Premium
Global
Translation
Press Release Network in Korea
Korean Language
About Us
News
Services
Contact Us
Search
Cancel
Search
Submit Press Release
Latest News
News by Region
Korea
World
News by Industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Health News Releases
Today May 1
June 14, 2022 10:40
Guardant Health Completes Purchase of Guardant Health AMEA Joint Venture
Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced it has purchased the remaining shares of Guardant Health AMEA, Inc., held by SoftBank and its affiliates, givin
June 13, 2022 11:25
Galderma Announces Positive Results in Two Phase III Studies for a Novel Liquid Formulation botulinumtoxinA (RelabotulinumtoxinA) for the Treatment of Glabellar Lines (frown) and Lateral Canthal Lines (crow’s Feet)
Galderma announced today at the Vegas Cosmetic Surgery & Aesthetic Dermatology meeting, topline results from two phase III clinical studies (NCT04249583, NCT04249687) demonstrating that Relabotulinumt
June 10, 2022 12:00
Takeda’s Dengue Vaccine Candidate Provides Continued Protection Against Dengue Fever Through 4.5 Years in Pivotal Clinical Trial
Takeda (TSE:4502/NYSE:TAK) today announced that its dengue vaccine candidate, TAK-003, prevented 84% of hospitalized dengue cases and 61% of symptomatic dengue cases, with no important safety risks id
June 10, 2022 10:30
Ferring Announces New Collaboration for Development of Olamkicept
Ferring Pharmaceuticals today announced it has entered into a strategic collaboration with I-Mab to further develop olamkicept in inflammatory bowel disease (IBD) and related inflammatory conditions.
June 08, 2022 16:40
Galderma to Present New Findings From Innovative Product Portfolio at the 2022 VCS Annual Symposium
Galderma, the leading company solely dedicated to advancing the future of dermatology, announced it will present four scientific presentations at the 2022 Vegas Cosmetic Surgery (VCS) & Aesthetic Derm
June 07, 2022 16:20
Parse Biosciences Announces Partnership with Molecular Diagnostics Korea
Parse Biosciences, a leading provider of scalable single-cell sequencing solutions, today announced a partnership with Molecular Diagnostics Korea (MDxK) that will expand its presence in Asia by provi
June 07, 2022 11:30
Merck Advances Development Programs in Oncology Focusing on Novel Mechanisms and Pathways
Merck, a leading science and technology company, today provided an update on the progress of the company’s innovative oncology development pipeline focused on DNA damage biology. With clinical program
June 07, 2022 10:18
High Solvent Properties of N-Methyl-2-Pyrrolidone Dominate The Aprotic Solvents Industry: Report Fact.MR
As per in-depth industry analysis by Fact.MR, a market research and competitive intelligence provider, the global aprotic solvents market is anticipated to rise at a CAGR of 4.2% from 2022 to 2032.
June 03, 2022 14:20
On One Year Anniversary, Organon Introduces Global ESG Strategy and Commitments with Publication of Inaugural ESG Report
Organon (NYSE: OGN), a global women’s healthcare company, today announced the publication of its inaugural Environmental, Social, and Governance (ESG) Report for 2021. The ESG Report introduces Organo
June 03, 2022 11:30
BOEHRINGER INGELHEIM ENTERS GLOBAL LICENSING AGREEMENT TO DEVELOP AND COMMERCIALIZE INNOVATIVE ANTIBODIES FROM A*STAR FOR TARGETED CANCER THERAPIES
Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) today announced a global licensing agreement under which Boehringer Ingelheim will obtain exclusive worldwide rights t
June 02, 2022 11:40
Galderma to Present Extensive New Clinical Data Across Its Portfolio of Neuromodulators, Fillers and Biostimulators at the IMCAS World Congress 2022
Galderma will present a range of new clinical data and analyses across its portfolio during nine poster sessions and two symposia at the upcoming International Master Course on Aging Science (IMCAS) W
June 02, 2022 11:15
Takeda Presents Latest Research from Oncology Portfolio and Pipeline at ASCO & EHA
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it will present data at two upcoming scientific congresses this spring: the 58th Annual Meeting of the America
June 02, 2022 10:20
Takeda and Moderna Announce Plans to Transfer Marketing Authorization for Spikevax™ COVID-19 Vaccine in Japan to Moderna
Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Takeda (TSE:4502/NYSE:TAK) announced to transfer the marketing authorization in Jap
May 30, 2022 16:00
Takeda and Seagen to Highlight ADCETRIS® Combination Data Showing Statistically Significant Improvement in Overall Survival (OS) for Patients with Advanced Hodgkin Lymphoma
Takeda Pharmaceutical Company Limited (TSE:4502) and Seagen Inc., (NASDAQ:SGEN) today announced that overall survival (OS) data from the Phase 3 ECHELON-1 clinical trial of an ADCETRIS® (brentuximab v
May 30, 2022 09:10
LintonPharm to Release Data on Catumaxomab for Advanced Gastric Cancer with Peritoneal Metastasis at 2022 ASCO Annual Meeting
LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging bispecific antibodies for cancer immunotherapy, announces that preliminary results of Catu
May 27, 2022 14:20
Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA
On March 16, 2022, Medisca, a global supplier of pharmaceutical ingredients and equipment, entered into an exclusive agreement with SUANFARMA, a European-based manufacturer and distributor of pharmace
May 27, 2022 10:10
Merck to Present Latest Research From Oncology Portfolio at ASCO 2022
Merck, a leading science and technology company, today announced the latest research representing the Company’s innovative oncology portfolio has been accepted for presentation at this year’s American
May 26, 2022 13:45
Covetrus to Be Acquired by Clayton, Dubilier & Rice and TPG at an Enterprise Valuation of Approximately $4 Billion
Covetrus® (NASDAQ: CVET) (“Covetrus” or the “Company”), a global leader in animal-health technology and services, today announced that it has entered into a definitive agreement pursuant to which fund
May 26, 2022 13:30
Frazier Life Sciences Adds Highly Experienced Biopharmaceutical Executive to Team
Frazier Life Sciences announced the addition of Tao Fu as a Venture Partner. He has over 25 years of business development, general management, operations, strategy, and commercial leadership experienc
May 26, 2022 10:20
Lumenis OptiLight Wins 2022 MedTech Breakthrough Award: Best New Technology Solution for Ophthalmology
Lumenis Be., a leading energy-based medical device company for aesthetic and eye care applications, today announced that OptiLight has received the highly competitive MedTech Breakthrough Award for “B
May 25, 2022 17:15
Ferring Presents New Analyses of Efficacy, Safety and Microbiome Composition Data at DDW 2022 for RBX2660 its Investigational Microbiota-Based Live Biotherapeutic
Ferring Pharmaceuticals today announced the presentation of four abstracts at Digestive Disease Week (DDW) 2022 that further characterize RBX2660, a potential first-in-class microbiota-based live biot
May 25, 2022 16:50
Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT04 and Reference Product Stelara®
Alvotech Holdings S.A. (“Alvotech”), a global biotech company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, today announced positive results from a
May 24, 2022 11:40
New Study Finds That Masimo PVi® May Be Useful in Helping ER Doctors Determine the Severity of Asthma Attacks in Pediatric Patients
Masimo (NASDAQ: MASI) today announced the findings of a retrospective study published in the American Journal of Emergency Medicine in which Dr. Gülsah Demir and colleagues at Tepecik Research and Tra
May 19, 2022 16:00
Regencell Bioscience Announces Additional EARTH Efficacy Trial Results Corroborating Effectiveness of its Investigational Liquid-Formula RGC-COV19TM in Eliminating Mild to Moderate COVID-19 Symptoms within the 6-Day Treatment Period
Regencell Bioscience Holdings Limited (NASDAQ: RGC): Results of EARTH efficacy trial (To view the table, please visit https://www.businesswire.com/news/home/20220518005682/en/) Regencell Bios
May 19, 2022 11:30
Dental Monitoring Launches the Virtual Practice Platform for a Comprehensive, Life-Long Patient Experience
Dental Monitoring, the industry-leading company that pioneered the field of intelligent orthodontics, launches the Virtual Practice Platform for a comprehensive, life-long patient experience. This
May 19, 2022 11:10
Sermo Survey Reveals New Lung & Breast Cancer Research Rated as Most Interesting by Oncologists Attending ASCO This Year
A new survey from Sermo, a physician-first online community and leader in global HCP insights, timed to the annual American Society of Clinical Oncology (ASCO) conference found that nearly half (47%)
May 18, 2022 16:45
Morinaga Milk Obtains the Registration of “New Food Ingredient” in China for Use of Its Probiotic Bifidobacterium longum BB536 in Infant and Toddler Foods
Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced its proprietary probiotic Bifidobacterium longum BB536 was approved by the National Health Comm
May 18, 2022 16:30
University of Nebraska Medical Center and ANANDA Scientific announce FDA approval of the IND for a Clinical Trial exploring Treatment for Post-Traumatic Stress Disorder (PTSD)
The University of Nebraska Medical Center (UNMC) and ANANDA Scientific Inc announce a collaboration in a new clinical trial investigating treatment for adults with Post-Traumatic Stress Disorder (PTSD
May 18, 2022 11:20
New Milestone Clinical Study Shows Postbiotic Urolithin A (Mitopure™) Improves Muscle Strength and Exercise Performance in Middle Aged Adults
Amazentis, a spin-off of the Swiss Federal Institute of Technology (EPFL) pioneering scientific breakthroughs in cellular health and nutrition, announced today that the peer-reviewed clinical and tran
May 17, 2022 16:40
Alvotech Announces Positive Results from a Pharmacokinetic Similarity Study for AVT04, a Proposed Biosimilar to Stelara®
Alvotech Holdings S.A. (“Alvotech”), a global biotech company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, today announced positive top-line result
May 17, 2022 14:40
Innovative AI software for the detection of pancreatic diseases: first-in-human application successful
Diseases of the pancreas can have serious consequences for patients and are difficult to diagnose. Early detection is crucial for the patient‘s chance of survival. In Europe today, more than 90 percen
May 17, 2022 11:40
Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO
Regencell Bioscience Holdings Limited (NASDAQ: RGC) (“Regencell” or the “Company”), an early-stage bioscience company focusing on the research, development and commercialization of Traditional Chinese
May 17, 2022 11:10
Xlear Teams Up With Dr. Ferrer BioPharma to Bring a Better User Experience to Nasal Hygiene
Today Xlear announced a new partnership with Dr. Ferrer BioPharma (DFBP), which will make Xlear nasal spray the first nasal hygiene tool to deploy the GentleMist nozzle—the next generation nasal spray
May 16, 2022 09:30
Boehringer Ingelheim’s latest investigational treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis
Today, Boehringer Ingelheim announced Phase II data for BI 1015550, a novel investigational phosphodiesterase 4B (PDE4B) inhibitor, that was published in The New England Journal of Medicine (NEJM). Th
May 13, 2022 10:00
Update on the timeline for Vifor Pharma tender offer
Regulatory News: CSL Limited (ASX: CSL; USOTC:CSLLY) yesterday announced an update regarding the Vifor Pharma AG acquisition. CSL has previously advised that it expected to be in a position to clos
May 12, 2022 13:30
Takeda Delivers Strong FY2021 Results; Continued Growth Momentum Expected in FY2022
Takeda (TOKYO:4502/NYSE:TAK) today announced strong financial results for fiscal year 2021 (period ended March 31, 2022), driven by the performance of its growth products, new product launches and str
May 11, 2022 15:20
Mawi DNA Technologies Launches NextSWAB™ For Accurate, More Reliable COVID-19 Test Results
Mawi DNA Technologies (Mawi), a medical device company focusing on the development of innovative technologies for biosampling, has launched the NextSWAB™, a 100% medical-grade plastic swab designed an
May 11, 2022 14:45
PCI Pharma Services Announces Major Manufacturing Expansion with $100 Million Investment in New England, Providing Global Capacity to Clients
PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced a major expansion of capabilities and capacity in aseptic liquid fill-finish and
May 10, 2022 10:30
TA Associates Announces Strategic Growth Investment in Zifo RnD Solutions
TA Associates (“TA”), a leading global growth private equity firm, today announced that the firm has completed a strategic growth investment in Zifo RnD Solutions (“Zifo”), a leading provider of scien
May 06, 2022 15:15
CureApp: World’s First Medical Device Regulatory Approval of Digital Therapeutic App for Hypertension
CureApp, Inc. (Head Office: Chuo-ku, Tokyo; CEO: Kohta Satake) was notified by the Ministry of Health, Labour and Welfare on April 26, 2022 that the company had received the medical device regulatory
May 06, 2022 09:40
Rhizen Pharmaceuticals AG Announces Promising Interim Data Presentation >From an Ongoing Phase II Study of Tenalisib (RP6530) in Locally Advanced or Metastatic Breast Cancer Patients At ESMO Breast Cancer Meeting 2022
Rhizen Pharmaceuticals AG (Rhizen), a Switzerland-based privately held, clinical-stage biopharmaceutical company announced today that it is presenting promising interim data from an ongoing Ph2 trial
May 04, 2022 15:35
Patient Safety Movement Foundation Announces Winners of 2021 Humanitarian and Lewis Blackman Awards
The Patient Safety Movement Foundation (PSMF), a global non-profit committed to achieving zero preventable patient deaths by 2030, announced the winners of its 2021 Humanitarian and Lewis Blackman awa
May 02, 2022 13:40
Groundbreaking research cooperation: The Medi-Globe Group and the IHU in Strasbourg are developing the world‘s first AI software for detecting pancreatic diseases
The Medi-Globe Group has entered into a groundbreaking research cooperation with the French Institut Hospitalo-Universitaire (IHU) in Strasbourg. The goal of the collaboration is the world‘s first AI
April 28, 2022 15:30
Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients
Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220427005801/en/ Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
April 27, 2022 17:25
94th Vifor Pharma Group Annual General Meeting
Regulatory News: At today’s 94th Annual General Meeting of Vifor Pharma Ltd., shareholders approved all proposed resolutions put forward by the Board of Directors. The Annual General Meeting was ag
April 27, 2022 16:30
Takeda Recognized as the 2022 ISPE Facility of the Year Awards Winner in Two Categories
Takeda (TSE:4502/NYSE:TAK) today announced that the International Society for Pharmaceutical Engineering (ISPE) has awarded the company top honors in the Supply Chain and Pharma 4.0™ categories for th
April 26, 2022 16:15
GemPharmatech, Leading Provider of Genetically Engineered Mouse Models, Goes Public on Shanghai Stock Exchange
GemPharmatech LLC is pleased to announce that on April 25, 2022, its parent company, GemPharmatech Co., Ltd., went public on the STAR MARKET of the Shanghai Stock Exchange under the stock code 688046.
April 26, 2022 14:05
Mawi iSWAB Microbiome-EL Enables Prime Discoveries’ Development of Rapid Extraction-Less COVID Diagnostic Assay
Mawi DNA Technologies (Mawi), a biotechnology company focusing on the development of innovative technologies for biosampling, announces that Prime Discoveries has successfully developed CovidDetect™,
April 25, 2022 11:30
Takeda Presents New Exploratory Analysis Showing Patients Treated With LIVTENCITY™ (Maribavir) Had Reductions in Hospitalization Rates and Length of Hospital Stay
Takeda (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it will present four company-sponsored abstracts at the Tandem Transplantation & Cellular Therapy Meetings in Salt Lake City, Utah, and the 3
April 21, 2022 17:20
Boehringer Ingelheim launches RenuTend™: a new stem cell therapy to improve the healing of tendon and suspensory ligament injuries in horses
It takes years of diligent training as well as a trusting relationship between horse and rider to reach their full potential as a team. That’s why a tendon or ligament injury can be devastating for ho
April 21, 2022 14:10
How Cloud Deployment In Big Data Analytics In Healthcare Industry Led To Gain Immense Traction In Asia Pacific: Fact.MR
According to the Fact.MR’s Latest Study, the global demand for big data analytics in healthcare is estimated at US$ 39.7 billion in 2022. Data as a technology has been adopted by healthcare industry s
April 19, 2022 16:30
Takeda Announces Approval of Nuvaxovid® COVID-19 Vaccine for Primary and Booster Immunization in Japan
Takeda (TSE:4502/NYSE:TAK) today announced that it has received manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for Nuvaxovid® Intramuscular Injection
April 19, 2022 15:00
Surging Hospitalization Rates For Numerous Chronic And Infectious Ailments Are Driving Demand For Hospital Supplies Market: Fact.MR
According to the latest Fact.MR analysis, the global hospital supplies market is predicted to grow at a CAGR of over 3%, reaching US$ 23 Bn by the end of the 2021-2031 forecast period, concludes Fact.
April 15, 2022 14:30
Kaneka Launches New PCR Test Kit for Identifying the COVID-19 Omicron (BA.1) and “Stealth” Omicron (BA.2) Variants
On March 31, Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka) released KANEKA RT-PCR Kit “SARS-CoV-2 (Omicron/Delta) ver.2”, a real-time PCR test kit capable of simultaneo
April 15, 2022 14:15
Advanced Clinical Continues Global Expansion Into Europe With New Office in Switzerland
Advanced Clinical, a clinical development and strategic resourcing organization, is pleased to announce its continued expansion into Europe with the opening of a new office in Zug, Switzerland. “We
April 15, 2022 09:30
Advancement In Oxygen Concentrators Industry Drives Revenue Share Upsurge By 2031... Projected To Top USD 5 Bn: Fact.MR's Latest Survey
As per a new report published by Fact.MR - Market research and competitive intelligence provider, the market for medical oxygen systems is anticipated to top US$ 5 Bn by 2031 and expand at a CAGR of 7
April 14, 2022 10:30
Takeda Announces Completion of Acquisition of Own Shares
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today provided an update on the status and announced the completion of the acquisition of its own shares, which has been carried
April 13, 2022 09:30
Takeda’s TAKHZYRO® (lanadelumab) Open Label Phase 3 Study Met Its Objectives in Children Ages 2 to <12 Years of Age With Hereditary Angioedema (HAE)
Takeda (TSE:4502/NYSE:TAK) today announced that the Phase 3 SHP643-301 study (NCT04070326) evaluating the safety profile and pharmacokinetics (PK) of TAKHZYRO® (lanadelumab) in patients 2 to
April 12, 2022 18:00
Top 10 Finalist Nurses Announced for Inaugural Aster Guardians Global Nursing Award
Aster Guardians Global Nursing Award has just announced its top 10 finalists hailing from across the world. These nurses have been selected from over 24,000 nurses who applied from over 184 countries,
April 12, 2022 10:45
DentalMonitoring, the Industry-leader in AI-powered Dental Software, Is Creating a New Business Unit, the DM Lab, as The Company Targets Continued Growth and Expansion
The purpose of the DM Lab will be to explore, test and validate business opportunities across the broad dental market, as DentalMonitoring expands its technological leadership as well as its geographi
April 12, 2022 09:15
The GXP Engaged Auditing Services Group of Companies Announces the Opening of Its UK Subsidiary, GXP Engaged Auditing Services UK Ltd.
As well as extending the reach of our comprehensive contract quality management and auditing services for our clients in the pharmaceutical, biotechnology, medical devices, nutrition and healthcare in
April 11, 2022 11:00
Rhizen Pharmaceuticals AG Presents Data on Its Differentiated PARP and DHODH Inhibitor Programs at AACR 2022
Rhizen Pharmaceuticals AG (Rhizen), a Switzerland-based privately held, clinical-stage oncology & inflammation-focussed biopharmaceutical company, announced the release of data on its differentiated n
April 08, 2022 14:40
LevitasBio Announces the LeviCell EOS System: A New Era in Sample Processing and Characterization
LevitasBio, Inc. today unveiled the LeviCell™ EOS System, their next generation solution for cell separation and enrichment, featuring higher throughput and simultaneous targeted selection of viable c
April 07, 2022 16:30
Alvotech and STADA Pave Way to Launching HUKYNDRA®(AVT02), a Citrate-free, High-concentration Biosimilar to Humira® by Resolving European Patent Dispute With AbbVie
Alvotech Holdings S.A. (“Alvotech”), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients worldwide, has today announced the resolu
April 07, 2022 09:55
BostonGene Announces $150 Million Series B Funding at a Multi-Billion Dollar Valuation, Propelling the Company to Unicorn Status
BostonGene today announced the completion of the $150 million Series B funding. NEC Corporation (NEC; TSE: 6701) led the financing with participation from Impact Investment Capital and Japan Industria
April 06, 2022 15:50
Takeda and the New York Academy of Sciences Announce 2022 Innovators in Science Award Winners
Takeda (TSE:4502/NYSE:TAK) and the New York Academy of Sciences today announced the winners of the fourth Innovators in Science Award for their excellence in, and commitment to, innovative science tha
April 06, 2022 15:00
Medline to Acquire ASID BONZ
Medline International B.V., a leading manufacturer and distributor of healthcare supplies in Europe, and Medi-Globe Group, headquartered in Germany, announced today that Medline has entered into a def
April 06, 2022 10:30
Saladax Biomedical, Inc. Acquires Intellectual Property Portfolio for Antipsychotic Drug Tests
Saladax Biomedical, Inc. (Saladax) is pleased to announce that it has acquired a patent portfolio for antipsychotic drug testing from Janssen Pharmaceutica NV. This intellectual property (IP) portfoli
April 06, 2022 09:45
South African Teaching Hospital Achieves CRE Superbug Decrease Following Novel Environmental Hygiene Intervention
Wits University Donald Gordon Medical Centre announced novel study results indicating for the first time that Ultraviolet (UV) room decontamination technology paired with manual cleaning protocols dec
April 06, 2022 08:40
Korean Research Team Establishes World’s First Tonsil Epithelial Organoids Model for SARS-CoV-2 Infection
The research team led by Professor Jongman Yoo (Cha University and CEO of ORGANOIDSCIENCES) along with Professor Young-Chang Lim (Konkuk University) and Dr. Meehyein Kim (Korea Research Institute of C
April 05, 2022 17:30
Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
In 2021, Boehringer Ingelheim again stepped up its annual investments in R&D to a new high in its 137-year history. The company spent 4.1 billion EUR on R&D (2020: 3.7 billion EUR), up 11.7%. R&D inve
April 05, 2022 14:00
Patient Safety Movement Foundation Announces Dates and Speaker Line-up for 8th Annual World Patient Safety, Science & Technology Summit
The Patient Safety Movement Foundation (PSMF) will host the 8th annual World Patient Safety, Science and Technology Summit (WPSSTS) virtually April 29 and April 30, 2022. The event is co-convened by t
April 04, 2022 14:10
DIAMOND trial: Veltassa® enables patients to achieve long-term potassium control and optimized RAASi therapy
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma today announced full results from its phase-IIIb DIAMOND trial showing that Veltassa® allowed patients to achieve long-te
April 04, 2022 14:00
Takeda Announces Candidates for Board of Directors at Upcoming Shareholders Meeting
Takeda (TOKYO:4502/NYSE:TAK) today announced that its Board of Directors will propose two new candidates for independent external directors at the 146th Ordinary Meeting of Shareholders on June 29, 20
April 04, 2022 09:30
Merck Shares Advances in MS Portfolio with Key Efficacy and Safety Data at AAN 2022
DARMSTADT, Germany--(BUSINESS WIRE)-- Merck, a leading science and technology company, today announced 13 abstracts from the Company’s multiple sclerosis (MS) portfolio will be presented at the 2022 A
April 01, 2022 11:15
Labcorp Renews Strategic Partnership with Medidata to Provide Suite of Clinical Trial Technologies and Services
Medidata, a Dassault Systèmes company, announced that Labcorp, a leading global life sciences company, has selected Medidata's technology platform to extend their 14-year partnership, the foundation o
March 30, 2022 17:30
ASICS Experiment Reveals Just One Week of Physical Inactivity Has a Similar Impact as a Week of Broken Sleep on Our State of Mind
Today, the impact of physical inactivity on our mental state has been revealed for the first time in the Mind Race[i] - an ASICS experiment in which regular exercisers paused their normal fitness rout
March 30, 2022 09:24
Increasing Demand for Closed Blood Sampling Systems to Substantially Surge Revenues with USD 135.83 Mn, Owing to Provisions of Needleless Blood Sampling Systems: Fact.MR’s Study
According to the Fact.MR Latest Analysis, global demand for closed blood sampling systems is slated to experience significant growth at 5.9% CAGR from 2021 to 2032, with the market value set to increa
March 30, 2022 09:15
Erbe Brings the Erbe Academy to Singapore
Education is one of the core pillars of our Erbe Group vision. The Erbe Academy program is one of our company‘s success stories. It provides a network for doctors, nurses and our company’s global sale
March 29, 2022 16:10
UAE Healthcare Powerhouse VPS Healthcare Eyes Global Expansion and Investments in Education & Research
Abu Dhabi-based VPS Healthcare, a leading UAE healthcare group, is preparing to expand boldly into new global markets, introducing the same personalised care and expertise to patients that has elevate
March 29, 2022 15:50
Spine Innovations Marks Milestone, Over 20,000 ESP Spinal Discs Implanted as Global Demand Grows
Since its formation as a wholly independent company in late 2020, Spine Innovations has continued to expand sales of its ESP spinal disc replacements, with more than 20,000 prostheses successfully imp
March 29, 2022 13:40
New Study Finds That Noninvasive and Continuous Hemoglobin Improved Transfusion Management and Outcomes in Pediatric Patients
Masimo (NASDAQ: MASI) today announced the findings of a retrospective study published in the Journal of Clinical Monitoring and Computing in which Dr. Ayten Saracoglu and colleagues at Marmara Univers
March 29, 2022 13:20
Takeda’s TAKHZYRO® (lanadelumab) Approved in Japan for Prophylaxis Against Acute Attacks of Hereditary Angioedema (HAE)
Takeda (TSE:4502/NYSE:TAK) today announced that it has received approval from the Ministry of Health, Labour and Welfare (MHLW) for TAKHZYRO® (lanadelumab) subcutaneous injection 300mg syringes for pr
March 29, 2022 11:50
Galderma to Present New Clinical Data and High Patient Satisfaction Across Their Portfolio of Dermal Fillers, Collagen Biostimulators and Liquid Neuromodulators at AMWC 2022
Galderma will present a range of new scientific data on its portfolio on their hyaluronic acid dermal filler range, their first liquid neuromodulator and their original collagen biostimulator at the A
March 29, 2022 11:00
The Medi-Globe Group opens the MGG Campus - a new training and virtual test laboratory
The Medi-Globe Group has opened its own training and virtual test laboratory at its headquarters in Achenmühle, Germany. The Medi-Globe Group Campus (MGG Campus) has state-of-the-art equipment with wh
March 28, 2022 15:00
Publication of definitive end result for Vifor Pharma tender offer
CSL Behring AG, Berne, Switzerland, a wholly-owned subsidiary of global biotechnology leader CSL Limited (ASX: CSL; USOTC: CSLLY), today announced the definitive notice of the end result of its public
March 28, 2022 11:45
Galderma to Highlight Latest Science and Innovation Across Its Product Portfolio at the 2022 AAD Annual Meeting
Galderma, the leading company solely dedicated to advancing the future of dermatology, announced it will be attending the 2022 American Academy of Dermatology Annual Meeting to showcase its latest app
March 28, 2022 10:00
STALICLA Completes Successful Phase 1b Trials for the First Precision Medicine in Autism Spectrum Disorder
STALICLA, a Swiss clinical stage biotech company leading omics-based drug development for patients with neurodevelopmental disorders (NDDs), announced today the highly successful completion of the pha
March 25, 2022 15:40
Tanner Pharma Increases Europe-Based Inventory of Leukine® to Expand Availability and Enhance Response to Potential Radiation Exposure Due to the Ongoing Conflict in Ukraine
Tanner Pharma Group, an international distributor of essential medicines, announced that it has significantly increased its inventory of Leukine (sargramostim, yeast-derived rhuGM-CSF) to be held in E
March 25, 2022 09:40
ViiV Healthcare announces label update for its long-acting HIV treatment, Cabenuva (cabotegravir, rilpivirine), to be initiated with or without an oral lead-in period
For media and investors only ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today announced
March 23, 2022 16:40
Publication of provisional end result for Vifor Pharma tender offer: Participation rate of 94 percent
Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220322006149/en/ AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL B
March 23, 2022 14:55
Alchemab Selected to Access NVIDIA Cambridge-1 Supercomputer to Advance Machine Learning Enabled Antibody Discovery
Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies and immune repertoire-based patient stratification tools, has been
March 22, 2022 09:02
Dental Prosthetics Sales In Asia Pacific To Top With A Market Valuation of More Than USD 50 Bn by 2030; Owing To The Rising Trends of Cosmetic Dentistry: Fact.MR
According to Fact.MR Latest Analysis, the global dental consumables market is projected to register growth at the rate of nearly 4% over the forecast period of 2020-2030, to reach a market valuation o
March 21, 2022 10:10
No Virus Transmission Detected at 300 Stores With Seoul Viosys UVC Air Purifying Sterilizer
Seoul Viosys (KOSDAQ: 092190), a global optical semiconductor company, provided free air purifying sterilizers applied with Violeds, its UV LED sterilization solution technology, to more than 300 self
March 17, 2022 16:30
Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online Traffic
Gelesis (NYSE: GLS), the maker of Plenity, announced preliminary results from its broad awareness media campaign that debuted January 31, 2022. Within the first three weeks, the company saw a 3-fold i
March 17, 2022 11:35
More Than Half of Physicians Have Been Asked By Patients for an Unapproved COVID-19 Treatment
A new survey from Sermo, a physician-first online community and leader in global HCP insights, found that physicians are facing a challenging onslaught of COVID-19 vaccine and treatment misinformation
March 17, 2022 10:15
Jardiance® (empagliflozin) Phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease
The EMPA-KIDNEY trial, evaluating the effect of empagliflozin in adults with chronic kidney disease (CKD), will stop early based on a recommendation from the trial’s Independent Data Monitoring Commit
March 16, 2022 21:05
Aleph Farms Reveals Its Strategy to Replace the Whole Cow as an Alternative to Intensive Cattle Farming
Aleph Farms, the first company to grow cultivated beef steaks, today announced it is expanding its product line to include a unique platform for cell-cultured collagen production. The company’s highly
March 16, 2022 09:07
Smartphone Penetration Is Encouraging The Mindfulness Meditation Apps Usage And Is Expected To Top With A Sales Volume of 180 Mn Latest Study By Fact.MR
As per the analysis conducted by Fact. MR, the global mindfulness meditation apps market is anticipated to procure a market value of USD 180 Mn through 2032. The increasing cases of depression, mood d
March 15, 2022 14:40
Dexcom G7 Receives CE Mark - Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today it has secured CE Mark (Conformité Européenne) for the Dexcom G7 Cont
«
6
7
8
9
10
»
100 per page
25 per page
50 per page
75 per page
100 per page
Distribute Your News to
KOREA
The largest press release distribution network in Korea
34,000 journalists
7,000 media outlets
345 industry channel
80,000 subscribers
Get Started
Global PR service
Reach Your Target
Audience in 160 Countries
powered by
Get Started
News by region
Korea
Overseas
News by industry
Health
Economy
Education
Finance
Technology
Life Style
Leisure
Culture & Entertainment
Transportation
Society
Heavy Industries
Environment
Government
Notice